Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - ATHERSYS, INC / NEW | d328702dex321.htm |
| EX-31.2 - EXHIBIT 31.2 - ATHERSYS, INC / NEW | d328702dex312.htm |
| EX-31.1 - EXHIBIT 31.1 - ATHERSYS, INC / NEW | d328702dex311.htm |
| EX-24.1 - EXHIBIT 24.1 - ATHERSYS, INC / NEW | d328702dex241.htm |
| EX-23.1 - EXHIBIT 23.1 - ATHERSYS, INC / NEW | d328702dex231.htm |
| EX-21.1 - EXHIBIT 21.1 - ATHERSYS, INC / NEW | d328702dex211.htm |
| 10-K - FORM 10-K - ATHERSYS, INC / NEW | d328702d10k.htm |
EXHIBIT 10.42
SUMMARY OF ATHERSYS, INC.
2017 CASH BONUS INCENTIVE PLAN
On January 11, 2017, the Board of Directors of Athersys, Inc. (the “Company”), based upon the recommendation of the Compensation Committee of the Board of Directors of the Company, approved a cash bonus incentive plan (the “Plan”) for the year ended December 31, 2017 for the named executive officers of the Company. The Plan provides that each participant is eligible to earn a bonus during the award term of January 1, 2017 through December 31, 2017. The Plan provides for the following target bonus percentages of the named executive officer’s salary during the award term, weighted as set forth below on the achievement of specified corporate goals, with the remainder based on individual/functional performance. The corporate goals include advancing the Company’s clinical programs for MultiStem, executing against the established operating plan and capital acquisition objectives, and advancement of strategic partnership and program activities. There is no formally adopted plan document for the Plan.
| Title |
Target Bonus |
Weighting on Corporate Goals |
||||||
| Chief Executive Officer |
60 | % | 100 | % | ||||
| President & Chief Operating Officer |
45 | % | 80 | % | ||||
| Executive Vice President & Chief Scientific Officer |
45 | % | 80 | % | ||||
| Senior Vice President of Finance |
35 | % | 60 | % | ||||